1. Home
  2. ADAP vs CPBI Comparison

ADAP vs CPBI Comparison

Compare ADAP & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • CPBI
  • Stock Information
  • Founded
  • ADAP 2008
  • CPBI 2023
  • Country
  • ADAP United Kingdom
  • CPBI United States
  • Employees
  • ADAP N/A
  • CPBI N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • CPBI
  • Sector
  • ADAP Health Care
  • CPBI
  • Exchange
  • ADAP Nasdaq
  • CPBI Nasdaq
  • Market Cap
  • ADAP 75.5M
  • CPBI 63.0M
  • IPO Year
  • ADAP 2015
  • CPBI N/A
  • Fundamental
  • Price
  • ADAP $0.27
  • CPBI $14.86
  • Analyst Decision
  • ADAP Buy
  • CPBI
  • Analyst Count
  • ADAP 6
  • CPBI 0
  • Target Price
  • ADAP $1.35
  • CPBI N/A
  • AVG Volume (30 Days)
  • ADAP 644.7K
  • CPBI 1.7K
  • Earning Date
  • ADAP 08-11-2025
  • CPBI 01-01-0001
  • Dividend Yield
  • ADAP N/A
  • CPBI N/A
  • EPS Growth
  • ADAP N/A
  • CPBI N/A
  • EPS
  • ADAP N/A
  • CPBI 0.96
  • Revenue
  • ADAP $179,639,000.00
  • CPBI $18,899,000.00
  • Revenue This Year
  • ADAP N/A
  • CPBI N/A
  • Revenue Next Year
  • ADAP $35.48
  • CPBI N/A
  • P/E Ratio
  • ADAP N/A
  • CPBI $15.54
  • Revenue Growth
  • ADAP 878.53
  • CPBI 9.64
  • 52 Week Low
  • ADAP $0.20
  • CPBI $10.11
  • 52 Week High
  • ADAP $1.48
  • CPBI $15.50
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 56.59
  • CPBI 47.43
  • Support Level
  • ADAP $0.23
  • CPBI $14.85
  • Resistance Level
  • ADAP $0.28
  • CPBI $14.99
  • Average True Range (ATR)
  • ADAP 0.02
  • CPBI 0.13
  • MACD
  • ADAP 0.00
  • CPBI -0.03
  • Stochastic Oscillator
  • ADAP 87.96
  • CPBI 9.51

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.

Share on Social Networks: